Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication – News-Medical.Net

Even though several vaccines have now been rolled out in a bid to end the pandemic of coronavirus disease 2019 (COVID-19) that has ravaged the world over the past 1.5 years, the delay in vaccine production and distribution is bound to leave many countries stranded without adequate supplies of vaccines for at least a year more. During this time, millions of cases may be added, many of which will require treatment.
New research by a team of scientists in the USA describes the potential utility of…

Click here to view the original article.